OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
DSP-6952, a novel 5-HT 4 receptor partial agonist, inhibits visceral hypersensitivity and ameliorates gastrointestinal dysfunction in experimental animals
Yukiko Mine, Tomohiro Itakura, Seiko Oku, et al.
European Journal of Pharmacology (2018) Vol. 826, pp. 123-132
Open Access | Times Cited: 14
Yukiko Mine, Tomohiro Itakura, Seiko Oku, et al.
European Journal of Pharmacology (2018) Vol. 826, pp. 123-132
Open Access | Times Cited: 14
Showing 14 citing articles:
Lactobacillus rhamnosus GG supernatant promotes intestinal mucin production through regulating 5-HT4R and gut microbiota
Yu Gu, Xiali Qin, Guoqiong Zhou, et al.
Food & Function (2022) Vol. 13, Iss. 23, pp. 12144-12155
Closed Access | Times Cited: 32
Yu Gu, Xiali Qin, Guoqiong Zhou, et al.
Food & Function (2022) Vol. 13, Iss. 23, pp. 12144-12155
Closed Access | Times Cited: 32
Efficacy and Safety of 5-HT4 Receptor Agonist Minesapride for Irritable Bowel Syndrome with Constipation in a Randomized Controlled Trial
Shin Fukudo, Masatoshi Nakamura, Tatsuto Hamatani, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 3, pp. 538-546.e8
Open Access | Times Cited: 28
Shin Fukudo, Masatoshi Nakamura, Tatsuto Hamatani, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 3, pp. 538-546.e8
Open Access | Times Cited: 28
Acupuncture and Moxibustion Intervention in Functional Dyspepsia: Gastric and Duodenal Regulation
Hongxiu Chen, Min He, Jiazhen Cao, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e35696-e35696
Open Access | Times Cited: 2
Hongxiu Chen, Min He, Jiazhen Cao, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e35696-e35696
Open Access | Times Cited: 2
Randomised clinical trial: minesapride vs placebo for irritable bowel syndrome with predominant constipation
Tatsuto Hamatani, Shin Fukudo, Yosuke Nakada, et al.
Alimentary Pharmacology & Therapeutics (2020) Vol. 52, Iss. 3, pp. 430-441
Open Access | Times Cited: 15
Tatsuto Hamatani, Shin Fukudo, Yosuke Nakada, et al.
Alimentary Pharmacology & Therapeutics (2020) Vol. 52, Iss. 3, pp. 430-441
Open Access | Times Cited: 15
The in vitro pharmacology and non-clinical cardiovascular safety studies of a novel 5-HT 4 receptor agonist, DSP-6952
Tadashi Tsubouchi, Takeshi Kunimatsu, Shinji Tsujimoto, et al.
European Journal of Pharmacology (2018) Vol. 826, pp. 96-105
Open Access | Times Cited: 12
Tadashi Tsubouchi, Takeshi Kunimatsu, Shinji Tsujimoto, et al.
European Journal of Pharmacology (2018) Vol. 826, pp. 96-105
Open Access | Times Cited: 12
Comparison of the Gut Microbiota Disturbance in Rat Models of Irritable Bowel Syndrome Induced by Maternal Separation and Multiple Early-life Adversity
Enqi Wu, Song Jingzhu, Pei Ling-peng, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 8
Enqi Wu, Song Jingzhu, Pei Ling-peng, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 8
Preclinical experimental models for assessing laxative activities of substances/products under investigation: a scoping review of the literature.
Patiwat Kongdang, Dumnoensun Pruksakorn, Nut Koonrungsesomboon
PubMed (2022) Vol. 14, Iss. 2, pp. 698-717
Closed Access | Times Cited: 5
Patiwat Kongdang, Dumnoensun Pruksakorn, Nut Koonrungsesomboon
PubMed (2022) Vol. 14, Iss. 2, pp. 698-717
Closed Access | Times Cited: 5
A 3‐Part Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DSP‐6952 in Healthy Japanese Subjects and Those With ≤3 Spontaneous Bowel Movements per Week
Takuya Yumizaki, Mika Maeda, Tomoe Fujita, et al.
Clinical Pharmacology in Drug Development (2019) Vol. 9, Iss. 3, pp. 353-365
Closed Access | Times Cited: 4
Takuya Yumizaki, Mika Maeda, Tomoe Fujita, et al.
Clinical Pharmacology in Drug Development (2019) Vol. 9, Iss. 3, pp. 353-365
Closed Access | Times Cited: 4
Thorough QT/QTc Study Shows That a Novel 5‐HT4 Receptor Partial Agonist Minesapride Has No Effect on QT Prolongation
Tatsuto Hamatani, Naoto Noda, Takeshi Takagaki, et al.
Clinical Pharmacology in Drug Development (2020) Vol. 9, Iss. 8, pp. 938-951
Closed Access | Times Cited: 4
Tatsuto Hamatani, Naoto Noda, Takeshi Takagaki, et al.
Clinical Pharmacology in Drug Development (2020) Vol. 9, Iss. 8, pp. 938-951
Closed Access | Times Cited: 4
The effect of 5-HT4 serotonin receptors in the CA3 hippocampal region on D-AP5-induced anxiolytic-like effects: Isobolographic analyses
Amin Charousaei, Mohammad Nasehi, Vahab Babapour, et al.
Behavioural Brain Research (2020) Vol. 397, pp. 112933-112933
Closed Access | Times Cited: 3
Amin Charousaei, Mohammad Nasehi, Vahab Babapour, et al.
Behavioural Brain Research (2020) Vol. 397, pp. 112933-112933
Closed Access | Times Cited: 3
Enterochromaffin cells and gastrointestinal diseases
Min-Jia Zhu, Ze-Jun Yang, Feifei Wang, et al.
Shijie huaren xiaohua zazhi (2019) Vol. 27, Iss. 2, pp. 117-124
Open Access | Times Cited: 1
Min-Jia Zhu, Ze-Jun Yang, Feifei Wang, et al.
Shijie huaren xiaohua zazhi (2019) Vol. 27, Iss. 2, pp. 117-124
Open Access | Times Cited: 1
Advances in understanding relationship between 5-hydroxytryptamine and its receptors and intestinal dysmotility in irritable bowel syndrome
Yin-Shu Wang, En-Kang Wang, Yangyang Meng, et al.
Shijie huaren xiaohua zazhi (2019) Vol. 27, Iss. 15, pp. 954-960
Open Access | Times Cited: 1
Yin-Shu Wang, En-Kang Wang, Yangyang Meng, et al.
Shijie huaren xiaohua zazhi (2019) Vol. 27, Iss. 15, pp. 954-960
Open Access | Times Cited: 1
Editorial: minesapride for irritable bowel syndrome with constipation-authors' reply
Tatsuto Hamatani, Shin Fukudo, Yosuke Nakada, et al.
Alimentary Pharmacology & Therapeutics (2020) Vol. 52, Iss. 4, pp. 715-716
Open Access
Tatsuto Hamatani, Shin Fukudo, Yosuke Nakada, et al.
Alimentary Pharmacology & Therapeutics (2020) Vol. 52, Iss. 4, pp. 715-716
Open Access
Pharmacokinetics, safety and metabolite profiling of minesapride, a novel 5-HT4 receptor partial agonist, in healthy elderly and young subjects
Tatsuto Hamatani, Yuta Shibue, Naoyuki Sawada, et al.
Drug Metabolism and Pharmacokinetics (2020) Vol. 35, Iss. 6, pp. 563-570
Open Access
Tatsuto Hamatani, Yuta Shibue, Naoyuki Sawada, et al.
Drug Metabolism and Pharmacokinetics (2020) Vol. 35, Iss. 6, pp. 563-570
Open Access
